rheumatology | Keywords | EQUATOR Network

skip to main content

Enhancing the QUAlity and Transparency Of health Research

Website translation help

Navigate this website

Home > Library > Reporting guideline

Blog Archives

20/05/2022 EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 20/05/2022 Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases: The Role of the IMPACT-RMD Toolkit 17/05/2022 EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology 10/11/2021 Implementing the 27 PRISMA 2020 Statement items for systematic reviews in the sport and exercise medicine, musculoskeletal rehabilitation and sports science fields: the PERSiST (implementing Prisma in Exercise, Rehabilitation, Sport medicine and SporTs science) guidance 19/02/2021 EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs) 11/01/2018 Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements 30/09/2013 Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries 13/08/2013 ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis 09/08/2013 Research reporting standards for percutaneous vertebral augmentation 15/07/2013 Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

Blog archives

Latest guest blogger

New resource for research teams to improve the reporting of implementation studies

In this blog post, Dr Louise Hull, an implementation research lead, discusses the development of a new resource to help improve the reporting of implementation studies.